Anesthesiology, Pain Medicine · Rock Hill, SC
NPI
1326039223
Since 2005
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
410 Herlong Ave S Ste 101
Rock Hill, SC, 29732
Phone (803) 909-3600
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
4,528 services
Medicare patients, 2024
341
Average age 75
Drug cost, 2024
$242K
2,720 prescriptions
Company payments, 2025
$471
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ratko Vujicic was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 2,186 times for 142 patients. In total Ratko Vujicic billed 4,528 services in 45 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,186 | 142 | $0.09 | $192 |
| 99214 Office E&M - Established | Office | 1,047 | 245 | $88.00 | $92K |
| 99213 Office E&M - Established | Office | 232 | 113 | $62.91 | $15K |
| 99203 Office E&M - New | Office | 122 | 122 | $78.26 | $9,547 |
| 27096 Joint Injection | Office | 103 | 63 | $158.82 | $16K |
| 76942 Ultrasound - Nonspecific | Office | 85 | 36 | $42.23 | $3,590 |
| 62323 Nerve Block Injection - Back | Office | 55 | 30 | $180.19 | $9,911 |
| 64450 Musculoskeletal | Office | 46 | 12 | $53.18 | $2,446 |
| 64493 Nerve Block Injection - Back | Office | 41 | 23 | $159.76 | $6,550 |
| 64494 Nerve Block Injection - Back | Office | 39 | 22 | $91.89 | $3,584 |
| 64483 Nerve Block Injection - Back | Office | 36 | 18 | $203.64 | $7,331 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 28 | 23 | $381.04 | $11K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 27 | 22 | $208.75 | $5,636 |
| 99215 Office E&M - Established | Office | 24 | 20 | $130.88 | $3,141 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 20 | 13 | $0.09 | $1.85 |
By year: 2022 $280K for 5,574 services; 2023 $227K for 4,320 services; 2024 $211K for 4,528 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 98 | 95 | $61.30 | $6,007 |
Medicare prescription drug claims, 2024
In 2024, the drug Ratko Vujicic prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 616 prescriptions and refills. In total Ratko Vujicic wrote 2,720 Medicare prescriptions that cost $242K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 616 | 616 | 78 | $16K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 510 | 510 | 73 | $11K |
| Tramadol Hcl Generic | 282 | 282 | 45 | $1,871 |
| Pregabalin Generic | 263 | 303 | 68 | $3,271 |
| Gabapentin Generic | 251 | 309 | 45 | $3,813 |
| Buprenorphine Generic | 248 | 248 | 43 | $59K |
| Belbuca Buprenorphine Hcl | 151 | 151 | 19 | $96K |
| Tizanidine Hcl Generic | 70 | 83 | 13 | $282 |
| Butrans Buprenorphine | 52 | 52 | Under 11 | $25K |
| Oxycodone Hcl Generic | 38 | 38 | Under 11 | $602 |
| Methocarbamol Generic | 27 | 29 | Under 11 | $324 |
| Methadone Hcl Generic | 18 | 18 | Under 11 | $280 |
| Movantik Naloxegol Oxalate | 15 | 15 | Under 11 | $5,781 |
| Baclofen Generic | 15 | 15 | Under 11 | $116 |
| Cyclobenzaprine Hcl Generic | 15 | 15 | Under 11 | $16.41 |
Brand drugs: 271 claims; generic drugs: 2,449 claims; opioid claims: 2,000.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ratko Vujicic $471 ($471 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $172.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.